Vitalhub Corp (OTCPK:VHIBF)
$ 5.13 -0.088 (-1.69%) Market Cap: 324.38 Mil Enterprise Value: 237.96 Mil PE Ratio: 58.97 PB Ratio: 1.69 GF Score: 80/100

Q4 2025 Vitalhub Corp Earnings Call Transcript

Mar 19, 2026 / 12:00PM GMT
Release Date Price: $4.88 (-13.94%)

Key Points

Positve
  • Vitalhub Corp (VHIBF) reported over $100 million in total revenue for the full year of 2025, marking a significant milestone.
  • The company achieved a 10% net organic growth in annual recurring revenues, reaching $96.1 million.
  • Adjusted EBITDA margins increased to 24%, demonstrating progress in integration and operational efficiency.
  • Vitalhub Corp (VHIBF) closed the year with $119.2 million in cash and no debt, indicating strong financial health.
  • The integration of acquisitions such as Novari and Induction is progressing well, contributing positively to the company's performance.
Negative
  • Gross margin decreased slightly to 79% from 81% in the prior year period.
  • Virtual care term license revenue declined by 4% sequentially.
  • There was a delay in reporting due to growth pains with a new auditor, although it was not material.
  • The NHS restructuring in the UK has slowed down operations and affected the shrewd product line.
  • Cash flow was negatively impacted this quarter, partly due to timing issues with cash collections and operational challenges in acquired companies.
Christian Sgro;Brian
Vitalhub Corp - Head of IR and M&A Specialist

(audio in progress)

fourth-quarter conference call.

With me on the call today are VitalHub's CEO, Dan Matlow; and CFO, Brian Goffenberg. (Event Instructions)

Before we begin, I will read our cautionary note regarding forward-looking information. Certain information to be discussed during this call contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, please review the forward-looking statements disclosure in the earnings press release and in our SEDAR filings.

As well, our commentary today will include adjusted financial measures, which are non-IFRS measures. These should be considered as a supplement to and not a substitute for IFRS measures. Reconciliations between the two can be found in our SEDAR filings.

With that, I will hand the call over to Brian to go over financial highlights for the quarter. Over to you, Brian.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot